Olmesartan, a widely prescribed blood pressure medication in the angiotensin receptor blocker (ARB) class, has a handful of significant drug interactions and a few medical situations where it should not be used at all. The most consequential involve other drugs that act on the same hormonal system that olmesartan targets, certain common over-the-counter painkillers, lithium, and pregnancy. Some of these interactions are shared by the entire ARB class, while at least one unusual side effect appears to be more specific to olmesartan itself.
Other Drugs That Act on the Same Blood Pressure System
Olmesartan lowers blood pressure by blocking the renin-angiotensin-aldosterone system, specifically by sitting on the receptor where angiotensin II would normally bind. ACE inhibitors (like lisinopril, enalapril, or ramipril) target a different step of the same system. Aliskiren, a direct renin inhibitor, targets yet another step. On paper, combining two of these drugs might seem like a way to get extra blood pressure control. In practice, the combination causes more harm than benefit for most people.
When olmesartan is combined with an ACE inhibitor or with aliskiren, the risk of dangerously high potassium levels rises substantially. A systematic review and meta-analysis found that combining aliskiren with an ACE inhibitor or an ARB raised the risk of high potassium by about 58% compared to using either drug alone.1PubMed Central. The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis A separate meta-analysis focused on heart failure and kidney disease patients found that dual blockade of this system increased the risk of kidney problems by about 40%, high potassium by 44%, and low blood pressure by 42%.2PubMed Central. Effects of dual blockade in heart failure and renal dysfunction: Systematic review and meta-analysis
The practical takeaway is straightforward: if you are already on olmesartan, you should not be started on an ACE inhibitor or aliskiren at the same time without a very specific reason and close monitoring. For people with diabetes, this combination is essentially contraindicated. If you have been prescribed two blood pressure drugs and both act on this system, that is worth a conversation with your prescriber.
NSAIDs Like Ibuprofen and Naproxen
Nonsteroidal anti-inflammatory drugs are one of the most practically important interactions because they are so easy to grab off the shelf without thinking. Ibuprofen, naproxen, and similar painkillers can blunt the blood-pressure-lowering effect of olmesartan, meaning your medication works less well when you take them regularly. The mechanism is straightforward: NSAIDs cause the kidneys to retain sodium and water, which pushes blood pressure up and partially cancels out what the ARB is doing.
More concerning is the kidney angle. Both NSAIDs and ARBs independently affect blood flow through the kidneys but in different ways. When combined, especially in someone who is also dehydrated or has underlying kidney issues, they can cause a sharp drop in kidney function. This risk is sometimes called the “triple whammy” when a diuretic is added to the mix. Occasional use of an NSAID for a headache is a lower-risk scenario than daily use for arthritis, but the interaction is dose-dependent and cumulative. Acetaminophen (paracetamol) is generally the safer over-the-counter pain option if you are on olmesartan long term.
Lithium
If you take lithium for bipolar disorder or another mood condition, adding olmesartan can push lithium levels into a toxic range. Lithium has a notoriously narrow therapeutic window, meaning the difference between an effective dose and a dangerous one is slim. ARBs reduce the kidney’s ability to clear lithium, so the drug accumulates.
Case reports have documented lithium intoxication in patients who were on an ARB alongside a thiazide diuretic, including a specific case involving olmesartan and hydrochlorothiazide in a 69-year-old patient who had been on the combination for an extended period without dose adjustments.3Farmakoterapia w Psychiatrii i Neurologii. Lithium intoxication in patients using angiotensin II receptor antagonists and hydrochlorothiazide: two case reports The risk is particularly pronounced when an ARB and a diuretic are combined, since both push lithium levels upward. If you need both olmesartan and lithium, the interaction does not necessarily mean you cannot use the pairing, but your lithium blood levels need to be checked more frequently, especially when starting or changing doses of either drug.
Bile Acid Sequestrants and the Timing Problem
Bile acid sequestrants like colesevelam (often prescribed for high cholesterol or blood sugar control) create an interaction that is less about danger and more about your olmesartan simply not working. These drugs bind to various substances in the gut, and olmesartan gets caught up in the process. When colesevelam and olmesartan are taken at the same time, the body absorbs roughly 39% less olmesartan than it should.4PubMed. The effects of colesevelam HCl on the single-dose pharmacokinetics of glimepiride, extended-release glipizide, and olmesartan medoxomil
That is a massive reduction. It means you could be faithfully taking your blood pressure medication every day and getting substantially less benefit because the colesevelam is soaking it up before it ever reaches your bloodstream. The fix is simple: stagger the doses. Taking the two drugs at least four hours apart largely eliminates the problem.4PubMed. The effects of colesevelam HCl on the single-dose pharmacokinetics of glimepiride, extended-release glipizide, and olmesartan medoxomil If you are on both medications and nobody has mentioned timing to you, it is worth raising with your pharmacist.
Potassium Supplements, Salt Substitutes, and High-Potassium Foods
Olmesartan, like all ARBs, tends to raise potassium levels as a side effect. This is normally mild and clinically insignificant. But if you are actively adding potassium from other sources, the cumulative effect can tip the balance into hyperkalemia, which at its worst can cause dangerous heart rhythm disturbances.
The most common culprits are potassium supplements (sometimes prescribed alongside a diuretic for a different reason), potassium-based salt substitutes (marketed as heart-healthy alternatives to table salt, which can contain substantial amounts of potassium chloride), and potassium-sparing diuretics like spironolactone. If you are on olmesartan and someone prescribes a potassium supplement or a potassium-sparing diuretic, your potassium levels should be monitored. As for salt substitutes, you do not necessarily need to avoid them entirely, but you should know they contain a meaningful dose of potassium and mention your use of them to your doctor.
Pregnancy
This is not a “be cautious” situation. Olmesartan and all other drugs that act on the renin-angiotensin system are contraindicated in pregnancy, especially in the second and third trimesters. The risk to the developing fetus is well-established and severe. Exposure can cause too little amniotic fluid, which leads to a cascade of problems including underdeveloped lungs, kidney damage, joint deformities, and skull defects. Fetal or neonatal death is a documented outcome.5Journal of Hypertension. Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study
One observational study found that the fetal toxicity risk from ARBs like olmesartan may actually exceed the risk from ACE inhibitors, the other major drug class in this family.5Journal of Hypertension. Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study If you become pregnant or are planning to become pregnant while on olmesartan, the drug should be stopped as soon as possible and an alternative blood pressure medication chosen. Women of childbearing age who are prescribed olmesartan should have this conversation upfront with their prescriber.
Renal Artery Stenosis
Renal artery stenosis, a narrowing of one or both arteries supplying blood to the kidneys, creates a situation where olmesartan can cause sudden kidney failure. In a healthy kidney, the renin-angiotensin system helps maintain the pressure gradient that drives filtration. When the blood supply is already compromised by a narrowed artery, blocking that system with an ARB can cause the pressure to drop below what is needed for the kidney to function. In one reported case, a 75-year-old man with bilateral renal artery stenosis developed acute kidney failure after just a single dose of olmesartan, with kidney function returning to normal only after the drug was discontinued.6PubMed. Olmesartan associated with acute renal failure in a patient with bilateral renal artery stenosis
This is a class-wide risk, not unique to olmesartan, but the single-dose case is a reminder that the effect can be dramatic and fast. The risk is highest in bilateral stenosis (both arteries narrowed) or in a person with only one functioning kidney whose artery is narrowed. Doctors typically check kidney function within the first couple of weeks of starting any ARB, but if you have known or suspected vascular disease, this check is especially important.
Olmesartan and Sprue-Like Enteropathy
This is where olmesartan genuinely distinguishes itself from other ARBs, and not in a good way. A small number of patients on olmesartan develop severe, chronic diarrhea with significant weight loss and damage to the lining of the small intestine. The condition closely mimics celiac disease, with the same type of intestinal changes visible on biopsy: villous atrophy and increased immune cells in the intestinal lining.7PubMed Central. Olmesartan-Induced Enteropathy
The original case series that brought this to attention came from the Mayo Clinic, where researchers identified a pattern of severe intestinal disease in patients on olmesartan who tested negative for celiac disease. Stopping the drug led to clinical improvement and, in many cases, complete histologic recovery of the intestinal lining.8Mayo Clinic Proceedings. Severe Spruelike Enteropathy Associated With Olmesartan Later case reports have echoed the same pattern: months or years of chronic diarrhea and weight loss on olmesartan, followed by rapid improvement once the drug is withdrawn. One case documented a 63-year-old man who lost 10 kg over two years on the drug, then regained the weight within six months of stopping it, with intestinal biopsy findings normalizing within 10 months.9PubMed Central. Olmesartan-Induced Enteropathy: A Rare Case of Chronic Diarrhea
The condition is rare, but it is probably underdiagnosed because the symptoms develop gradually and overlap with common gastrointestinal problems. The FDA added a warning about sprue-like enteropathy to olmesartan’s label in 2013. If you have been on olmesartan for months or years and have developed unexplained chronic diarrhea, nausea, or weight loss, mention the medication specifically to your doctor. This is one situation where switching to a different ARB can resolve the problem entirely.
Over-the-Counter Decongestants
Oral decongestants containing pseudoephedrine or phenylephrine work by constricting blood vessels, which is exactly the opposite of what olmesartan is trying to do. Using them occasionally during a cold is unlikely to cause a crisis, but regular or heavy use can meaningfully raise blood pressure and partially cancel out your medication. People who reach for decongestant-containing cold remedies frequently, or who use nasal sprays containing oxymetazoline for more than a few days, should be aware of this antagonism. Nasal saline rinses and antihistamines are alternatives that do not push blood pressure up.
Licorice Root and Glycyrrhizin
Real licorice (not the artificially flavored candy, which is harmless in this context) contains glycyrrhizin, a compound that mimics aldosterone in the body. Aldosterone tells the kidneys to retain sodium and excrete potassium. In a patient who was taking both olmesartan and an ACE inhibitor, co-administration of glycyrrhizin contributed to a condition called pseudoaldosteronism, with potassium levels dropping from a safe range above 4 mEq/L down to 2.5 mEq/L over the course of several months.10J-STAGE / Internal Medicine. Pseudoaldosteronism Caused by Combined Administration of Cilostazol and Glycyrrhizin Dangerously low potassium can cause muscle weakness, heart palpitations, and in extreme cases, cardiac arrest.
This interaction is worth knowing about because glycyrrhizin shows up in places people do not expect: herbal teas, traditional remedies, some imported candies, and certain herbal supplements. It can also raise blood pressure independently, working against the olmesartan. If you enjoy licorice-flavored products, check whether they contain real licorice root extract. Small, occasional consumption is low-risk for most people, but regular use alongside an ARB is asking for trouble with both blood pressure and potassium.
How Olmesartan Affects Nighttime Blood Pressure
One physiological effect of olmesartan that is relevant to understanding its place among blood pressure drugs is its influence on the body’s daily blood pressure rhythm. Normally, blood pressure dips during sleep. In many people with hypertension, that dip is blunted or absent, a pattern called “non-dipping” that is associated with higher cardiovascular risk. Olmesartan has been shown to help restore the normal nighttime blood pressure decline, possibly by promoting sodium excretion during the daytime hours, which reduces the body’s need to push out excess sodium overnight via higher pressure.11Journal of Hypertension. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis
This is relevant to the interaction picture because it underscores why high sodium intake and sodium-retaining drugs (like NSAIDs) can specifically undermine what olmesartan is doing. The drug is not just lowering blood pressure in a generic way; it is reshaping the pattern of how the kidneys handle sodium throughout the day. Anything that disrupts that sodium handling, whether it is a drug interaction, excessive dietary salt, or a supplement that shifts electrolyte balance, has the potential to erode the benefit.
When to Talk to Your Pharmacist, Not Just Your Doctor
Many of the interactions above involve over-the-counter products and supplements that your prescribing doctor may never learn about unless you volunteer the information. Pharmacists are often better positioned to catch these problems because they see everything you are picking up, prescription and non-prescription alike. If you are starting a new supplement, switching pain relievers, or adding a cold remedy, running it by the pharmacist takes two minutes and costs nothing. For olmesartan specifically, the items most worth flagging are regular NSAID use, potassium-containing salt substitutes, licorice root products, and any new blood pressure or heart medication. The bile acid sequestrant timing issue is another one that pharmacists often catch when prescribers overlook it.
One pattern that deserves extra vigilance: many combination products bundle olmesartan with hydrochlorothiazide (a thiazide diuretic) under brand names like Benicar HCT. The diuretic component adds its own interaction profile, including a higher lithium toxicity risk and a different potassium dynamic (thiazides lower potassium, which partly offsets the ARB’s tendency to raise it, but creates new risks when paired with glycyrrhizin or in the setting of dehydration). If you are on a combination tablet, you are managing two drugs’ worth of interactions, even though you are only swallowing one pill.